Gastro-esophageal Reflux Disease (GERD) Completed Phase Trials for Omeprazole (DB00338)

Also known as: Gastroesophageal Reflux Disease / Gastro-esophageal Reflux Disease / GERD / GERD Gastroesophageal Reflux Disease / Gastro-Oesophageal Reflux Disease / Gastrooesophageal reflux disease / GERD (Gastroesophageal Reflux Disease) / Esophageal Reflux / GERD - Gastro-Esophageal Reflux Disease / Gastroesophageal Reflux Disease (GERD) / Gastro-esophageal Reflux Diseases / Oesophageal reflux / Esophagitis / Gastrooesophageal reflux / Gastroesophageal reflux / Esophageal reflux NOS

IndicationStatusPhase
DBCOND0077290 (Gastro-esophageal Reflux Disease (GERD))CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02685150Endoscopic Tri-Modal Imaging to Distinguish Functional Dyspepsia From Reflux DiseaseDiagnostic
NCT02893709Factors Influencing the Human Gut Microbiome Profile in Multi-ethnic Groups of the Singapore Community (FAMES)Basic Science
NCT03793556Evaluation of GERDOFF Efficacy in Combination With Proton Pump InhibitorTreatment
NCT02555852Proton Pump Inhibitors and Risk of Community-acquired Pneumonia
NCT01389401Salivary Epidermal Growth Factor (EGF) Concentration Before and After Treatment of Reflux Laryngitis